MRNXDefiance Daily Target 2X Long MRNA ETF

Defiance Daily Target 2X Long MRNA ETF is a leveraged exchange-traded fund designed to provide daily investment results that are two times the performance of Moderna, Inc. The fund uses derivatives, including swap agreements and listed options, to create amplified exposure to Moderna’s share price without holding the stock directly. It is built for short-term trading and resets its exposure each day, making it a tactical instrument rather than a long-term tracker. The ETF focuses on Moderna, a biotechnology company centered on messenger RNA-based medicines and vaccines, so the product appeals to market participants seeking concentrated exposure to the company’s role in mRNA innovation, vaccine development, and related therapeutic applications. Defiance Daily Target 2X Long MRNA ETF is part of Defiance’s lineup of single-stock leveraged products aimed at active investors who want targeted exposure to a specific healthcare name through a listed fund structure.